Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit polyclonal c-Jun (Phospho-Ser243) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human c-Jun around the phosphorylation site of serine 243 (P-L-SP-P-I). |
| Modifications | Phospho-specific |
Rabbit polyclonal 4E-BP1 (Phospho-Ser64) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human 4E-BP1 around the phosphorylation site of serine 64 (R-N-SP-P-V) |
| Modifications | Phospho-specific |
Rabbit polyclonal FKHR (Phospho-Ser256) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human FKHR around the phosphorylation site of serine 256 (A-A-SP-M-D). |
| Modifications | Phospho-specific |
Rabbit polyclonal STAT3 (Phospho-Tyr705) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human STAT3 around the phosphorylation site of tyrosine 705 (A-P-YP-L-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal Trk A (Phospho-Tyr701) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Trk A around the phosphorylation site of tyrosine 701 (I-L-YP-R-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal PAK1 (Phospho-Ser199) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PAK1/2 around the phosphorylation site of serine 199 (T-K-SP-V-Y). |
| Modifications | Phospho-specific |
Rabbit polyclonal p53 (Phospho-Ser15) antibody
| Applications | IHC, WB |
| Reactivities | Human, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human p53 around the phosphorylation site of Serine 15 (P-L-SP-Q-E). |
| Modifications | Phospho-specific |
Rabbit polyclonal p90 RSK (Phospho-Thr573) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human P90RSK around the phosphorylation site of threonine 573 (L-M-TP-P-C). |
| Modifications | Phospho-specific |
Rabbit polyclonal NMDAR1 (Phospho-Ser890) antibody
| Applications | IF, IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human NMDAR1 around the phosphorylation site of serine 890 (A-S-SP-F-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal PAK1 (Phospho-Ser204) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PAK1 around the phosphorylation site of serine 204 (T-R-SP-V-I). |
| Modifications | Phospho-specific |
Rabbit polyclonal MKK6 (Phospho-Ser207) antibody
| Applications | IHC, WB |
| Reactivities | Human, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human MKK3 around the phosphorylation site of Serine 189(V-D-SP-V-A). |
| Modifications | Phospho-specific |
Rabbit anti-FOXO3A (FKHRL1, Phospho-Ser253) polyclonal antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanFKHRL1 around the phosphorylation site of serine 253 (A-V-SP-M-D). |
| Modifications | Phospho-specific |
Rabbit anti-PRKAA2 (AMPK1/AMPK2, Phospho-Ser485/Ser491) polyclonal antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanAMPK1/AMPK2 around the phosphorylation site of serine 485/491 (S-G- SP-V-S). |
| Modifications | Phospho-specific |
Rabbit polyclonal Estrogen Receptor-a (Ser102) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Estrogen Receptor-a around the phosphorylation site of serine 102 (L-N-SP-V-S). |
| Modifications | Phospho-specific |
Rabbit polyclonal Trk B (Tyr515) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Trk B around the phosphorylation site of tyrosine 515 (P-Q-YP-F-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-Trk B antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | he antiserum was produced against synthesized peptide derived from Internal of human Trk B |
| Modifications | Phospho-specific |
Rabbit polyclonal KDR / VEGFR2 (Tyr1214) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human VEGFR2 around the phosphorylation site of tyrosine 1214 (F-H-YP-D-N). |
| Modifications | Phospho-specific |
Rabbit polyclonal PDK1 (Tyr9) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PDK1 around the phosphorylation site of tyrosine 9 (Q-L-YP-D-A). |
| Modifications | Phospho-specific |
Rabbit polyclonal Shc (Tyr349) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Shc around the phosphorylation site of tyrosine349 (H-Q-YP-Y-N) |
| Modifications | Phospho-specific |
Rabbit polyclonal Transcription Factor 3 / E2A (Thr355) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human E2A around the phosphorylation site of threonine 355 (P-S-TP-P-V). |
| Modifications | Phospho-specific |
Rabbit polyclonal Claudin 5 (Tyr217) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Claudin 5 around the phosphorylation site of tyrosine 217 (K-N-YP-V). |
| Modifications | Phospho-specific |
Rabbit polyclonal ILK (Ser246) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human ILK around the phosphorylation site of serine 246 (I-F-SP-H-P). |
| Modifications | Phospho-specific |
Rabbit polyclonal MAP3K8 (Ser400) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human MAP3K8 around the phosphorylation site of serine 400 (C-Q-SP-L-D). |
| Modifications | Phospho-specific |
Rabbit polyclonal MEF2A (Ser408) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human MEF2A around the phosphorylation site of serine 408 (P-I-SP-P-P). |
| Modifications | Phospho-specific |
Rabbit polyclonal HER2 (Tyr1248) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | HER2 (phospho-Tyr1248) antibody detects endogenous levels of HER2 only when phosphorylated at tyrosine 1248. |
| Modifications | Phospho-specific |
Rabbit polyclonal HSP90B (Ser254) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human HSP90B around the phosphorylation site of serine 254 (V-G-SP-D-E). |
| Modifications | Phospho-specific |
Rabbit polyclonal NF-kB p65 (Ser281) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human NF-kB p65 around the phosphorylation site of serine 281 (E-L-SP-E-P) |
| Modifications | Phospho-specific |
Rabbit polyclonal DARPP-32 (Thr34) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human DARPP-32 around the phosphorylation site of threonine 34 (R-P-TP-P-A). |
| Modifications | Phospho-specific |
Rabbit polyclonal PYK2 (Tyr579) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PYK2 around the phosphorylation site of tyrosine 579 (E-D-YP-Y-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal Chk2 (Thr387) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Chk2 around the phosphorylation site of threonine 387 (C-G-TP-P-T). |
| Modifications | Phospho-specific |
Rabbit polyclonal MER/SKY (Tyr749/681) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human MER/SKY around the phosphorylation site of tyrosine 749/681 (K-I-YP-S-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal IRS-1 (Ser636) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human IRS-1 around the phosphorylation site of serine 636 (P-M-SP-P-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal EPHA3/4/5 (Tyr779/833) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human EPHA3/4/5 around the phosphorylation site of tyrosine 779 (A-A-YP-T-T). |
| Modifications | Phospho-specific |
Rabbit polyclonal C-RAF (Thr269) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human C-RAF around the phosphorylation site of threonine 269 (S-T-TP-L-P). |
| Modifications | Phospho-specific |
Rabbit polyclonal AKT1/2/3 (Tyr315/316/312) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human AKT1/2/3 around the phosphorylation site of tyrosine 315/316/312 (P-E-YP-L-A). |
| Modifications | Phospho-specific |
Rabbit polyclonal APLP2 (Tyr755) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human APLP2 around the phosphorylation site of tyrosine 755 (P-T-YP-K-Y). |
| Modifications | Phospho-specific |
Rabbit polyclonal Tyrosine Hydroxylase (Ser40) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Tyrosine Hydroxylase around the phosphorylation site of serine 40 (R-Q-SP-L-I). |
| Modifications | Phospho-specific |
Rabbit polyclonal CREB (Ser133) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human CREB around the phosphorylation site of serine 133 (R-P-SP-Y-R). |
| Modifications | Phospho-specific |
Rabbit polyclonal Ephrin B1/B2 (Tyr329) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Ephrin B1/B2 around the phosphorylation site of tyrosine 329 (P-V-YP-I-V). |
| Modifications | Phospho-specific |
Rabbit polyclonal Glutamate receptor 2 (Ser880) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Glutamate receptor 2 around the phosphorylation site of serine 880 (I-E-SP-V-K). |
| Modifications | Phospho-specific |
Rabbit polyclonal JunB(Ser79) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human JunB around the phosphorylation site of Serine 79. |
| Modifications | Phospho-specific |
Rabbit polyclonal IkB-beta (Ser23) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human: Ser23, Mouse: Ser23, Rat: Ser23 |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human I?B-β around the phosphorylation site of serine 23. |
| Modifications | Phospho-specific |
Rabbit polyclonal CNOT2 (Ser101) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human CNOT2 around the phosphorylation site of serine 101 (S-L-SP-Q-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal PAK2 (Ser197) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PAK2 around the phosphorylation site of serine 197 (T-R-SP-V-I). |
| Modifications | Phospho-specific |
Rabbit polyclonal PAK3 (Ser154) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PAK3 around the phosphorylation site of serine 154 (Y-M-SP-F-T). |
| Modifications | Phospho-specific |
Rabbit polyclonal PPP1R2 (Ser120+Ser121) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PPP1R2 around the phosphorylation site of serine 120 and serine 121 (Q-E-SP-SP-GE). |
| Modifications | Phospho-specific |
Rabbit polyclonal Ras-GRF1 (Ser916) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Ras-GRF1 around the phosphorylation site of serine 916 (R-M-SP-L-A). |
| Modifications | Phospho-specific |
Rabbit polyclonal S6 Ribosomal Protein (Ser235+Ser236) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human S6 Ribosomal Protein around the phosphorylation site of serine 235and 236 (R-L-SP-SP-L-R). |
| Modifications | Phospho-specific |
Active filters
Reactivities
- Rat
Applications
- IHC
Clonalities
- Polyclonal
Modifications
- Phospho-specific
Filter by
Category
Target Symbol
- AKT1 (8)
- STAT1 (6)
- ATF2 (5)
- BAD (5)
- CREB1 (5)
- FOXO1 (4)
- IRS1 (4)
- KDR (4)
- MEF2A (4)
- NFKBIA (4)
- NTRK2 (4)
- PAK1 (4)
- RB1 (4)
- RELA (4)
- VASP (4)
- C1ORF215 (3)
- DOK1 (3)
- FOXO4 (3)
- JUN (3)
- JUNB (3)
- PRKCQ (3)
- PTK2B (3)
- RAF1 (3)
- SRC (3)
- STAT3 (3)
- STAT5A (3)
- TH (3)
- ACACA (2)
- ADD1 (2)
- BCL2L1 (2)
- CDC25A (2)
- CFL1 (2)
- CHEK2 (2)
- CHUK (2)
- CTNNB1 (2)
- EFNB1 (2)
- ERBB2 (2)
- GAB2 (2)
- GSK3A (2)
- HDAC2 (2)
- HDAC5 (2)
- IGF1R (2)
- JUND (2)
- LIMK2 (2)
- MAP2K4 (2)
- MAP2K6 (2)
- MAPK14 (2)
- MAPKAPK2 (2)
- NFKBIB (2)
- NR3C1 (2)
- NTRK1 (2)
- PDCD4 (2)
- PPP1R1B (2)
- PRKCD (2)
- PRKCZ (2)
- PTEN (2)
- PXN (2)
- RPS6KA1 (2)
- RPS6KB1 (2)
- SHC1 (2)
- SMAD3 (2)
- STAT4 (2)
- STK39 (2)
- YWHAZ (2)
- ZAP70 (2)
- ACO1 (1)
- AHR (1)
- APC (1)
- APLP2 (1)
- APP (1)
- ASAP1 (1)
- BCAR1 (1)
- BCL2L11 (1)
- BLK (1)
- BLNK (1)
- BRAF (1)
- CALM1 (1)
- CAMK2A (1)
- CAMK2B (1)
- CASP6 (1)
- CASP9 (1)
- CCNC (1)
- CCND3 (1)
- CD6 (1)
- CDK2 (1)
- CEBPA (1)
- CLDN5 (1)
- CNOT2 (1)
- CSNK1A1 (1)
- CTBP1 (1)
- CTTN (1)
- CYP2E1 (1)
- DDR1 (1)
- DNM1 (1)
- DPYSL2 (1)
- EGFR (1)
- EIF2AK3 (1)
- EIF4E (1)
- EIF4EBP1 (1)
- ELK1 (1)
Antibody Hosts
Isotypes
Conjugates
Families
- Druggable Genome (267)
- Protein Kinase (100)
- Transcription Factors (93)
- Transmembrane (40)
- ES Cell Differentiation/IPS (35)
- Stem cell - Pluripotency (23)
- Stem cell relevant signaling - JAK/STAT signaling pathway (11)
- Nuclear Hormone Receptor (6)
- Phosphatase (5)
- Secreted Protein (5)
- Cancer stem cells (4)
- Adult stem cells (3)
- Ion Channels: Glutamate Receptors (3)
- Stem cell relevant signaling - DSL/Notch pathway (3)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (3)
- Embryonic stem cells (2)
- GPCR (2)
- Protease (2)
- Induced pluripotent stem cells (1)
- Ion Channels: Other (1)
- Ion Channels: Potassium (1)
- P450 (1)
Pathways
- Pathways in cancer (86)
- Neurotrophin signaling pathway (66)
- MAPK signaling pathway (65)
- Focal adhesion (62)
- Chemokine signaling pathway (61)
- Prostate cancer (58)
- ErbB signaling pathway (54)
- Chronic myeloid leukemia (50)
- Pancreatic cancer (48)
- T cell receptor signaling pathway (48)
- Insulin signaling pathway (46)
- Toll-like receptor signaling pathway (42)
- Fc gamma R-mediated phagocytosis (39)
- Acute myeloid leukemia (36)
- VEGF signaling pathway (36)
- Adipocytokine signaling pathway (35)
- B cell receptor signaling pathway (35)
- Colorectal cancer (34)
- Endometrial cancer (34)
- Apoptosis (33)
- GnRH signaling pathway (33)
- Non-small cell lung cancer (33)
- Small cell lung cancer (33)
- Glioma (32)
- Jak-STAT signaling pathway (31)
- Epithelial cell signaling in Helicobacter pylori infection (30)
- Melanoma (30)
- Fc epsilon RI signaling pathway (29)
- Tight junction (28)
- Regulation of actin cytoskeleton (27)
- Renal cell carcinoma (25)
- Leukocyte transendothelial migration (24)
- Progesterone-mediated oocyte maturation (24)
- Natural killer cell mediated cytotoxicity (22)
- mTOR signaling pathway (21)
- Calcium signaling pathway (19)
- Endocytosis (19)
- Wnt signaling pathway (19)
- Amyotrophic lateral sclerosis (ALS) (18)
- Axon guidance (18)
- Cell cycle (18)
- Melanogenesis (18)
- RIG-I-like receptor signaling pathway (18)
- NOD-like receptor signaling pathway (17)
- Adherens junction (16)
- Long-term potentiation (16)
- Alzheimer's disease (14)
- Cytosolic DNA-sensing pathway (14)
- Metabolic pathways (14)
- Vascular smooth muscle contraction (14)
- Bladder cancer (13)
- Gap junction (13)
- Huntington's disease (12)
- Long-term depression (11)
- Oocyte meiosis (11)
- p53 signaling pathway (10)
- Type II diabetes mellitus (9)
- Neuroactive ligand-receptor interaction (8)
- Pathogenic Escherichia coli infection (8)
- Phosphatidylinositol signaling system (8)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (7)
- Hypertrophic cardiomyopathy (HCM) (7)
- Thyroid cancer (7)
- Antigen processing and presentation (6)
- Cytokine-cytokine receptor interaction (6)
- Dilated cardiomyopathy (6)
- Vibrio cholerae infection (6)
- Basal cell carcinoma (5)
- Inositol phosphate metabolism (5)
- TGF-beta signaling pathway (5)
- Olfactory transduction (4)
- Cell adhesion molecules (CAMs) (3)
- Hedgehog signaling pathway (3)
- Notch signaling pathway (3)
- Parkinson's disease (3)
- Primary immunodeficiency (3)
- Prion diseases (3)
- Systemic lupus erythematosus (3)
- Viral myocarditis (3)
- ECM-receptor interaction (2)
- Fatty acid biosynthesis (2)
- PPAR signaling pathway (2)
- Propanoate metabolism (2)
- Pyruvate metabolism (2)
- Regulation of autophagy (2)
- Ribosome (2)
- Tyrosine metabolism (2)
- Alanine (1)
- Arachidonic acid metabolism (1)
- Arginine and proline metabolism (1)
- Butanoate metabolism (1)
- Cardiac muscle contraction (1)
- Citrate cycle (TCA cycle) (1)
- Dorso-ventral axis formation (1)
- Drug metabolism - cytochrome P450 (1)
- Ether lipid metabolism (1)
- Glycerophospholipid metabolism (1)
- Glyoxylate and dicarboxylate metabolism (1)
- Linoleic acid metabolism (1)
- Metabolism of xenobiotics by cytochrome P450 (1)
- Non-homologous end-joining (1)
- RNA degradation (1)
- Sphingolipid metabolism (1)
- Taste transduction (1)
- Taurine and hypotaurine metabolism (1)
- Type I diabetes mellitus (1)
- Ubiquitin mediated proteolysis (1)
- aspartate and glutamate metabolism (1)
- beta-Alanine metabolism (1)